- Home
- FRGE vs SCPH Comparison
FRGE vs SCPH Comparison
Compare FRGE & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRGE
- SCPH
- Stock Information
- Founded
- FRGE 2014
- SCPH 2013
- Country
- FRGE United States
- SCPH United States
- Employees
- FRGE N/A
- SCPH N/A
- Industry
- FRGE Computer Software: Prepackaged Software
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- FRGE Technology
- SCPH Health Care
- Exchange
- FRGE Nasdaq
- SCPH Nasdaq
- Market Cap
- FRGE 175.1M
- SCPH 173.6M
- IPO Year
- FRGE N/A
- SCPH 2017
- Fundamental
- Price
- FRGE $18.93
- SCPH $3.87
- Analyst Decision
- FRGE Buy
- SCPH Strong Buy
- Analyst Count
- FRGE 5
- SCPH 3
- Target Price
- FRGE $38.25
- SCPH $14.00
- AVG Volume (30 Days)
- FRGE 117.5K
- SCPH 301.8K
- Earning Date
- FRGE 08-06-2025
- SCPH 08-13-2025
- Dividend Yield
- FRGE N/A
- SCPH N/A
- EPS Growth
- FRGE N/A
- SCPH N/A
- EPS
- FRGE N/A
- SCPH N/A
- Revenue
- FRGE $85,383,000.00
- SCPH $41,982,000.00
- Revenue This Year
- FRGE $18.22
- SCPH $108.95
- Revenue Next Year
- FRGE $29.35
- SCPH $73.83
- P/E Ratio
- FRGE N/A
- SCPH N/A
- Revenue Growth
- FRGE 16.04
- SCPH 138.10
- 52 Week Low
- FRGE $6.60
- SCPH $1.94
- 52 Week High
- FRGE $24.45
- SCPH $5.65
- Technical
- Relative Strength Index (RSI)
- FRGE 73.21
- SCPH 54.08
- Support Level
- FRGE $18.15
- SCPH $3.77
- Resistance Level
- FRGE $19.94
- SCPH $4.03
- Average True Range (ATR)
- FRGE 0.97
- SCPH 0.18
- MACD
- FRGE 0.19
- SCPH -0.07
- Stochastic Oscillator
- FRGE 84.67
- SCPH 19.70
About FRGE Forge Global Holdings Inc.
Forge Global Holdings Inc is a financial service platform created to serve the needs of the private market. It provides marketplace infrastructure, data services, and technology solutions for private market participants. The company offers a trusted trading platform, proprietary data and insights to inform investment strategies, along with custody services to help companies, shareholders, institutions and accredited investors confidently navigate and transact in the private market.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.